Clinical Trials Directory

Trials / Conditions / Peripheral Nervous System Agents

Peripheral Nervous System Agents

12 registered clinical trials studyying Peripheral Nervous System Agents — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
NCT07210463
Merz Aesthetics GmbHPhase 3
RecruitingA Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
NCT07122193
Merz North America, Inc.Phase 3
RecruitingNebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting
NCT06752759
Theresa Jacob, PhD, MPHPhase 3
RecruitingNatural History of Depression, Bipolar Disorder and Suicide Risk
NCT06462196
National Institute of Mental Health (NIMH)—
CompletedOral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
NCT05615948
Maimonides Medical CenterPhase 4
WithdrawnRescue Quadratus Lumborum Blocks for Post-cesarean Pain
NCT04397458
The University of Texas Health Science Center, HoustonPhase 4
CompletedTransversus Abdominis Plan Block, Ultrasound or Laparoscopic?
NCT04634721
Ankara City Hospital BilkentN/A
TerminatedNatural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
NCT04489420
Celularity IncorporatedPhase 1
UnknownNatural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
NCT04309084
Celularity IncorporatedPhase 1
TerminatedNatural Killer Cell (CYNK-001) Infusions in Adults with AML
NCT04310592
Celularity IncorporatedPhase 1
CompletedEvaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectom
NCT03294109
University of California, Los AngelesPhase 4
CompletedDetermination of Minimum Effective Volume of Local Anesthetic in Patients Undergoing Ultrasound-Guided Infracl
NCT03838120
Ankara City Hospital BilkentPhase 4